Clinical Trial Update: Effect of 50 and 100 IU Doses of Botox A Toxin Injection in BPH Patients. [EARLY_Phase 1]

View source ↗

Summary

An early Phase 1 study evaluating the safety and tolerability of intraprostatic injections of onabotulinumtoxinA (Botox) at 50 and 100 IU in men with benign pro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• Botox (onabotulinumtoxinA) (onabotulinumtoxinA)

Snippet

Sponsor: Beni-Suef University | Conditions: Benign Prostatic Hyperplasia | EARLY_Phase 1 | Status: COMPLETED